These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 19479688)

  • 1. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
    Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
    Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
    Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility, utilization, and costs in a California Medicaid lupus population.
    Nichol MB; Shi S; Knight TK; Wallace DJ; Weisman MH
    Arthritis Rheum; 2004 Dec; 51(6):996-1003. PubMed ID: 15593358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population.
    Furst DE; Clarke A; Fernandes AW; Bancroft T; Gajria K; Greth W; Iorga SR
    Lupus; 2013 Mar; 22(3):268-78. PubMed ID: 23340996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis.
    Aghdassi E; Zhang W; St-Pierre Y; Clarke AE; Morrison S; Peeva V; Landolt-Marticorena C; Su J; Reich H; Scholey J; Herzenberg A; Pope JE; Peschken C; ; Wither JE; Fortin PR
    J Rheumatol; 2011 Apr; 38(4):658-66. PubMed ID: 21159829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
    Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
    Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis.
    Carls G; Li T; Panopalis P; Wang S; Mell AG; Gibson TB; Goetzel RZ
    J Occup Environ Med; 2009 Jan; 51(1):66-79. PubMed ID: 19136875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population.
    Furst DE; Clarke A; Fernandes AW; Bancroft T; Gajria K; Greth W; Iorga SR
    J Med Econ; 2013; 16(4):500-9. PubMed ID: 23363329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group.
    Clarke AE; Petri MA; Manzi S; Isenberg DA; Gordon C; Senecal JL; St Pierre Y; Joseph L; Penrod J; Fortin PR; Sutcliffe N; Goulet JR; Choquette D; Grodzicky T; Danoff DS; Ho V; Esdaile JM
    J Rheumatol; 1999 Jul; 26(7):1500-11. PubMed ID: 10405937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
    Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
    Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
    J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of treatment of childhood-onset systemic lupus erythematosus.
    Brunner HI; Sherrard TM; Klein-Gitelman MS
    Arthritis Rheum; 2006 Apr; 55(2):184-8. PubMed ID: 16583393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period.
    Bell CF; Wu B; Huang SP; Rubin B; Averell CM; Chastek B; Hulbert EM
    BMC Health Serv Res; 2024 May; 24(1):691. PubMed ID: 38822336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study.
    He X; Zhu X; Tang Z; Gairy K; Juliao P; Wu Z; Han S
    Value Health Reg Issues; 2024 Sep; 43():101001. PubMed ID: 38850589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
    Clarke AE; Urowitz MB; Monga N; Hanly JG
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare utilization and costs of systemic lupus erythematosus in Medicaid.
    Kan HJ; Song X; Johnson BH; Bechtel B; O'Sullivan D; Molta CT
    Biomed Res Int; 2013; 2013():808391. PubMed ID: 23484162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
    Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
    J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.